Download
s00109-020-01989-6.pdf 2,82MB
WeightNameValue
1000 Titel
  • Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes
1000 Autor/in
  1. Pabel, Steffen |
  2. Reetz, Florian |
  3. Dybkova, Nataliya |
  4. Shomroni, Orr |
  5. Salinas, Gabriela |
  6. Mustroph, Julian |
  7. Hammer, Karin P. |
  8. Hasenfuss, Gerd |
  9. Hamdani, Nazha |
  10. Maier, Lars S. |
  11. Streckfuss-Bömeke, Katrin |
  12. Sossalla, Samuel |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-09
1000 Erschienen in
1000 Quellenangabe
  • 98(12):1689-1700
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00109-020-01989-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679329/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The SGLT2 inhibitor empagliflozin improved cardiovascular outcomes in patients with diabetes. As the cardiac mechanisms remain elusive, we investigated the long-term effects (up to 2 months) of empagliflozin on excitation-contraction (EC)-coupling in human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CM) in a blinded manner. IPSC from 3 donors, differentiated into pure iPSC-CM (4 differentiations), were treated with a clinically relevant concentration of empagliflozin (0.5 μmol/l) or vehicle control. Treatment, data acquisition, and analysis were conducted externally blinded. Epifluorescence microscopy measurements in iPSC-CM showed that empagliflozin has neutral effects on Ca
1000 Sacherschließung
lokal Calcium/metabolism [MeSH]
lokal Induced Pluripotent Stem Cells/cytology [MeSH]
lokal Humans [MeSH]
lokal Action Potentials/drug effects [MeSH]
lokal Benzhydryl Compounds/pharmacology [MeSH]
lokal iPSC-CM
lokal Cell Differentiation [MeSH]
lokal Glucosides/pharmacology [MeSH]
lokal Original Article
lokal Myocytes, Cardiac/physiology [MeSH]
lokal Myocytes, Cardiac/cytology [MeSH]
lokal Sarcoplasmic Reticulum/metabolism [MeSH]
lokal Excitation Contraction Coupling/drug effects [MeSH]
lokal Empagliflozin
lokal Sodium-Glucose Transporter 2 Inhibitors/pharmacology [MeSH]
lokal Electrophysiology
lokal Myocytes, Cardiac/drug effects [MeSH]
lokal Cells, Cultured [MeSH]
lokal EC-coupling
lokal Sarcoplasmic Reticulum/drug effects [MeSH]
lokal Calcium Signaling/drug effects [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UGFiZWwsIFN0ZWZmZW4=|https://frl.publisso.de/adhoc/uri/UmVldHosIEZsb3JpYW4=|https://frl.publisso.de/adhoc/uri/RHlia292YSwgTmF0YWxpeWE=|https://frl.publisso.de/adhoc/uri/U2hvbXJvbmksIE9ycg==|https://frl.publisso.de/adhoc/uri/U2FsaW5hcywgR2FicmllbGE=|https://frl.publisso.de/adhoc/uri/TXVzdHJvcGgsIEp1bGlhbg==|https://frl.publisso.de/adhoc/uri/SGFtbWVyLCBLYXJpbiBQLg==|https://frl.publisso.de/adhoc/uri/SGFzZW5mdXNzLCBHZXJk|https://frl.publisso.de/adhoc/uri/SGFtZGFuaSwgTmF6aGE=|https://frl.publisso.de/adhoc/uri/TWFpZXIsIExhcnMgUy4=|https://frl.publisso.de/adhoc/uri/U3RyZWNrZnVzcy1Cw7ZtZWtlLCBLYXRyaW4=|https://orcid.org/0000-0001-8034-2673
1000 Hinweis
  • DeepGreen-ID: 6e637383524e4a01970eb357dd6cb5be ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6443066.rdf
1000 Erstellt am 2023-04-26T17:00:57.564+0200
1000 Erstellt von 322
1000 beschreibt frl:6443066
1000 Zuletzt bearbeitet Thu Oct 19 13:56:06 CEST 2023
1000 Objekt bearb. Thu Oct 19 13:56:06 CEST 2023
1000 Vgl. frl:6443066
1000 Oai Id
  1. oai:frl.publisso.de:frl:6443066 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source